198 related articles for article (PubMed ID: 26426676)
1. Sitagliptin increases acute pancreatitis risk within 2 years of its initiation: A retrospective cohort analysis of the National Health Insurance database in Taiwan.
Tseng CH
Ann Med; 2015; 47(7):561-9. PubMed ID: 26426676
[TBL] [Abstract][Full Text] [Related]
2. Sitagliptin and heart failure hospitalization in patients with type 2 diabetes.
Tseng CH
Oncotarget; 2016 Sep; 7(38):62687-62696. PubMed ID: 27409676
[TBL] [Abstract][Full Text] [Related]
3. Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: A population-based case-control study in Taiwan.
Liao KF; Lin CL; Lai SW; Chen WC
Eur J Intern Med; 2016 Jan; 27():76-9. PubMed ID: 26433909
[TBL] [Abstract][Full Text] [Related]
4. Sitagliptin and pancreatic cancer risk in patients with type 2 diabetes.
Tseng CH
Eur J Clin Invest; 2016 Jan; 46(1):70-9. PubMed ID: 26584246
[TBL] [Abstract][Full Text] [Related]
5. Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes.
Tseng CH
Oncotarget; 2017 Mar; 8(12):19057-19064. PubMed ID: 27661113
[TBL] [Abstract][Full Text] [Related]
6. Sitagliptin May Reduce Breast Cancer Risk in Women With Type 2 Diabetes.
Tseng CH
Clin Breast Cancer; 2017 Jun; 17(3):211-218. PubMed ID: 27986440
[TBL] [Abstract][Full Text] [Related]
7. Sitagliptin use and thyroid cancer risk in patients with type 2 diabetes.
Tseng CH
Oncotarget; 2016 Apr; 7(17):24871-9. PubMed ID: 27029076
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl Peptidase-4 Inhibitor Use Is Not Associated With Acute Pancreatitis in High-Risk Type 2 Diabetic Patients: A Nationwide Cohort Study.
Chang CH; Lin JW; Chen ST; Lai MS; Chuang LM; Chang YC
Medicine (Baltimore); 2016 Feb; 95(7):e2603. PubMed ID: 26886601
[TBL] [Abstract][Full Text] [Related]
9. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
Tseng CH
Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Outcomes of Sitagliptin in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Population-Based Cohort Study in Taiwan.
Wang SH; Chen DY; Lin YS; Mao CT; Tsai ML; Hsieh MJ; Chou CC; Wen MS; Wang CC; Hsieh IC; Hung KC; Chen TH
PLoS One; 2015; 10(6):e0131122. PubMed ID: 26115092
[TBL] [Abstract][Full Text] [Related]
11. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
Tseng CH
Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
[TBL] [Abstract][Full Text] [Related]
12. Incretin-based pharmacotherapy and risk of adverse pancreatic events in the ethnic Chinese with diabetes mellitus: A population-based study in Taiwan.
Tseng CM; Liao WC; Chang CY; Lee CT; Tseng CH; Hsu YC; Lin JT
Pancreatology; 2017; 17(1):76-82. PubMed ID: 27743712
[TBL] [Abstract][Full Text] [Related]
13. Association of Sitagliptin with cardiovascular outcome in diabetic patients: a nationwide cohort study.
Yang TY; Liaw YP; Huang JY; Chang HR; Chang KW; Ueng KC
Acta Diabetol; 2016 Jun; 53(3):461-8. PubMed ID: 26687195
[TBL] [Abstract][Full Text] [Related]
14. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes.
Tseng CH
Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842
[TBL] [Abstract][Full Text] [Related]
15. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
Tseng CH
Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
[TBL] [Abstract][Full Text] [Related]
16. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
17. Does Sitagliptin Affect the Rate of Osteoporotic Fractures in Type 2 Diabetes? Population-Based Cohort Study.
Majumdar SR; Josse RG; Lin M; Eurich DT
J Clin Endocrinol Metab; 2016 May; 101(5):1963-9. PubMed ID: 26930183
[TBL] [Abstract][Full Text] [Related]
18. Anti-diabetic therapies and the risk of acute pancreatitis: a nationwide retrospective cohort study from Taiwan.
Chang HY; Hsieh CF; Singh S; Tang W; Chiang YT; Huang WF
Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):567-75. PubMed ID: 25851403
[TBL] [Abstract][Full Text] [Related]
19. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan.
Lai SW; Muo CH; Liao KF; Sung FC; Chen PC
Am J Gastroenterol; 2011 Sep; 106(9):1697-704. PubMed ID: 21577242
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone may reduce thyroid cancer risk in patients with type 2 diabetes.
Tseng CH
Ann Med; 2013 Dec; 45(8):539-44. PubMed ID: 24215589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
